Dental studies and AtlasPROfilax®

Effect of AtlasPROfilax® Therapy on symptoms related to temporomandibular dysfunction, bruxism and the relationship of the dental midlines

Author/a: Dr. Victoria Eugenia Gutiérrez Navas, D.D.S Orto Spec.

Location: Bucaramanga, Santander (Colombia)

Study conducted: 2012-2013

Keywords: atlasprofilax, therapy, ATM, disorder, temporomandibular

Abstract: The aim of this study was to describe the effect of AtlasPROfilax® therapy on symptoms related to Temporomandibular Dysfunction (TMD), bruxism and on mandibular deviations during the opening and closing trajectory in a cohort of patients. Methodology: A descriptive observational follow-up study was carried out on 151 patients who attended the control 30 or 40 days after the therapy; in addition, a sub-sample of 71 patients was retaken and photographic analysis was carried out. Sociodemographic and clinical variables reported by the patient (at articular level pain, noise, jumping, blocking, limitation in opening and bruxism) and clinical variables taken from the photographic analysis (deviation from the midline in occlusion, opening and their difference) were taken. AtlasPROfilax® therapy reduced TMD-related symptoms and also reduced midline deviation in occlusion and aperture, but a Controlled Clinical Trial (CCT) with three and six months follow-up is required for further evaluation of the effectiveness of this therapeutic alternative.